Notice is given under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“Act”), of the following application to register a trade name product under section 9(1) of the Act:

Trade Name: Numelvi

Reference: A012149

Active Ingredient and Concentration:

30g/kg Atinvicitinib

Formulation Type: Tablet

Application method/administration route:

Oral. Once daily with food at a dose of 0.8–1.2mg/kg of Atinvicitinib.

Use Claim:

For the treatment of pruritus, inflammation and clinical manifestations associated with allergic dermatitis including atopic dermatitis in dogs.

Any person may make a written submission to the director-general concerning this application. Under sections 16 and 17 of the Act, a written submission:

1. must state in full the reasons for making the submission;
2. may state any decision sought on that application; and
3. must be received by the director-general no later than 30 working days after the date of this notice.

Each submission must state the trade name product(s) to which it relates. Under section 18 of the Act, a copy of every submission will be forwarded to the applicant.

The following address is:

1. where submissions on this application are to be sent;
2. where requests for copies of the public information relating to the application can be sent;
3. where public information relating to the application can be viewed; and
4. the director-general’s address for service:

ACVM Team, Ministry for Primary Industries, Charles Fergusson Building, 38–42 Bowen Street, Pipitea, Wellington 6011. Postal Address: PO Box 2526, Wellington 6140. Email: acvm.consultation@mpi.govt.nz.

MPI encourages submission by email.

The applicant’s address for service is:

Schering-Plough Animal Health Limited, 33 Whakatiki Street, Upper Hutt 5018. Postal Address: Private Bag 908, Upper Hutt 5140.

Dated at Wellington this 11th day of October 2024.

IMOGEN DEAR, Team Manager Operations, Ministry for Primary Industries (acting under delegated authority).